These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 21106781)

  • 1. The I222V neuraminidase mutation has a compensatory role in replication of an oseltamivir-resistant influenza virus A/H3N2 E119V mutant.
    Simon P; Holder BP; Bouhy X; Abed Y; Beauchemin CA; Boivin G
    J Clin Microbiol; 2011 Feb; 49(2):715-7. PubMed ID: 21106781
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Generation and characterization of recombinant pandemic influenza A(H1N1) viruses resistant to neuraminidase inhibitors.
    Pizzorno A; Bouhy X; Abed Y; Boivin G
    J Infect Dis; 2011 Jan; 203(1):25-31. PubMed ID: 21148493
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Substitution of I222L-E119V in neuraminidase from highly pathogenic avian influenza H7N9 virus exhibited synergistic resistance effect to oseltamivir in mice.
    Tang J; Gao R; Liu L; Zhang S; Liu J; Li X; Fang Q; Feng Z; Xu C; Huang W; Wang D
    Sci Rep; 2021 Aug; 11(1):16293. PubMed ID: 34381119
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Progressive emergence of an oseltamivir-resistant A(H3N2) virus over two courses of oseltamivir treatment in an immunocompromised paediatric patient.
    Hurt AC; Leang SK; Tiedemann K; Butler J; Mechinaud F; Kelso A; Downie P; Barr IG
    Influenza Other Respir Viruses; 2013 Nov; 7(6):904-8. PubMed ID: 23551973
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of multidrug-resistant influenza A/H3N2 viruses shed during 1 year by an immunocompromised child.
    Baz M; Abed Y; McDonald J; Boivin G
    Clin Infect Dis; 2006 Dec; 43(12):1555-61. PubMed ID: 17109288
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combinatorial effect of two framework mutations (E119V and I222L) in the neuraminidase active site of H3N2 influenza virus on resistance to oseltamivir.
    Richard M; Ferraris O; Erny A; Barthélémy M; Traversier A; Sabatier M; Hay A; Lin YP; Russell RJ; Lina B
    Antimicrob Agents Chemother; 2011 Jun; 55(6):2942-52. PubMed ID: 21422222
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessing the viral fitness of oseltamivir-resistant influenza viruses in ferrets, using a competitive-mixtures model.
    Hurt AC; Nor'e SS; McCaw JM; Fryer HR; Mosse J; McLean AR; Barr IG
    J Virol; 2010 Sep; 84(18):9427-38. PubMed ID: 20631138
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antiviral susceptibility profile of influenza A viruses; keep an eye on immunocompromised patients under prolonged treatment.
    Kossyvakis A; Mentis AA; Tryfinopoulou K; Pogka V; Kalliaropoulos A; Antalis E; Lytras T; Meijer A; Tsiodras S; Karakitsos P; Mentis AF
    Eur J Clin Microbiol Infect Dis; 2017 Feb; 36(2):361-371. PubMed ID: 27848039
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Secondary substitutions in the hemagglutinin and neuraminidase genes associated with neuraminidase inhibitor resistance are rare in the Influenza Resistance Information Study (IRIS).
    Roosenhoff R; Schutten M; Reed V; Clinch B; van der Linden A; Fouchier RAM; Fraaij PLA
    Antiviral Res; 2021 May; 189():105060. PubMed ID: 33713731
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Detection of E119V and E119I mutations in influenza A (H3N2) viruses isolated from an immunocompromised patient: challenges in diagnosis of oseltamivir resistance.
    Okomo-Adhiambo M; Demmler-Harrison GJ; Deyde VM; Sheu TG; Xu X; Klimov AI; Gubareva LV
    Antimicrob Agents Chemother; 2010 May; 54(5):1834-41. PubMed ID: 20194700
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cell culture-selected substitutions in influenza A(H3N2) neuraminidase affect drug susceptibility assessment.
    Tamura D; Nguyen HT; Sleeman K; Levine M; Mishin VP; Yang H; Guo Z; Okomo-Adhiambo M; Xu X; Stevens J; Gubareva LV
    Antimicrob Agents Chemother; 2013 Dec; 57(12):6141-6. PubMed ID: 24080660
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The epidemiology and spread of drug resistant human influenza viruses.
    Hurt AC
    Curr Opin Virol; 2014 Oct; 8():22-9. PubMed ID: 24866471
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Emergence of an oseltamivir-resistant influenza A/H3N2 virus in an elderly patient receiving a suboptimal dose of antiviral prophylaxis.
    Roussy JF; Abed Y; Bouhy X; Boivin G
    J Clin Microbiol; 2013 Dec; 51(12):4234-6. PubMed ID: 24088848
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oseltamivir resistance in an influenza A (H3N2) virus isolated from an immunocompromised patient during the 2014-2015 influenza season in Alberta, Canada.
    Chaudhry A; Bastien N; Li Y; Scott A; Pabbaraju K; Stewart D; Wong S; Drews SJ
    Influenza Other Respir Viruses; 2016 Nov; 10(6):532-535. PubMed ID: 27442795
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Different drug-resistant influenza A(H3N2) variants in two immunocompromised patients treated with oseltamivir during the 2011-2012 influenza season in Italy.
    Piralla A; Gozalo-Margüello M; Fiorina L; Rovida F; Muzzi A; Colombo AA; Alessandrino PE; Baldanti F
    J Clin Virol; 2013 Sep; 58(1):132-7. PubMed ID: 23810646
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A novel neuraminidase deletion mutation conferring resistance to oseltamivir in clinical influenza A/H3N2 virus.
    Abed Y; Baz M; Boivin G
    J Infect Dis; 2009 Jan; 199(2):180-3. PubMed ID: 19046066
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antiviral resistance due to deletion in the neuraminidase gene and defective interfering-like viral polymerase basic 2 RNA of influenza A virus subtype H3N2.
    Trebbien R; Christiansen CB; Fischer TK
    J Clin Virol; 2018 May; 102():1-6. PubMed ID: 29448067
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oseltamivir-resistant influenza viruses isolated in South Korea from 2005 to 2010.
    Cho HG; Choi JH; Lee HK; Mun SK; Lee JB; Jho EH; Kang C; Lim YH
    Arch Virol; 2013 Nov; 158(11):2365-70. PubMed ID: 23690054
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neuraminidase inhibitor susceptibility and neuraminidase enzyme kinetics of human influenza A and B viruses circulating in Thailand in 2010-2015.
    Tewawong N; Marathe BM; Poovorawan Y; Vongpunsawad S; Webby RJ; Govorkova EA
    PLoS One; 2018; 13(1):e0190877. PubMed ID: 29324781
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pandemic H1N1 2009 influenza virus with the H275Y oseltamivir resistance neuraminidase mutation shows a small compromise in enzyme activity and viral fitness.
    Brookes DW; Miah S; Lackenby A; Hartgroves L; Barclay WS
    J Antimicrob Chemother; 2011 Mar; 66(3):466-70. PubMed ID: 21172786
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.